{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:14:56Z","timestamp":1791897296292,"version":"4.3.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004716","name":"Suzhou University of Science and Technology","doi-asserted-by":"publisher","award":["SYW2024186"],"award-info":[{"award-number":["SYW2024186"]}],"id":[{"id":"10.13039\/501100004716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.phymed.2026.157910","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:08:21Z","timestamp":1769792901000},"page":"157910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Pedunculoside ameliorates metabolic dysfunction-associated steatotic liver disease by targeting HNRNPA1 and modulating PPAR\u03b1 signaling pathway to enhance Mitochondrial Fatty Acid \u03b2-Oxidation"],"prefix":"10.1016","volume":"153","author":[{"given":"Yang","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8870-2207","authenticated-orcid":false,"given":"Jingyun","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xining","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huazhou","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xizhen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0711-7335","authenticated-orcid":false,"given":"Kun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.phymed.2026.157910_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102377","article-title":"Resmetirom\u2019s approval: highlighting the need for comprehensive approaches in NASH therapeutics","volume":"48","author":"Alshehade","year":"2024","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"3","key":"10.1016\/j.phymed.2026.157910_bib0002","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/1874467212666190111165015","article-title":"A contemporary overview of PPAR\u03b1\/\u03b3 dual agonists for the management of diabetic dyslipidemia","volume":"12","author":"Balakumar","year":"2019","journal-title":"Curr. Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.phymed.2026.157910_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101506","article-title":"Steatotic liver disease, MASLD and risk of chronic kidney disease","volume":"50","author":"Bilson","year":"2024","journal-title":"Diabetes Metab."},{"issue":"8","key":"10.1016\/j.phymed.2026.157910_bib0004","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1021\/acs.analchem.1c00071","article-title":"Negative SPR signals during low molecular weight analyte recognition","volume":"93","author":"Bonnet","year":"2021","journal-title":"Anal. Chem."},{"issue":"5","key":"10.1016\/j.phymed.2026.157910_bib0005","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of ppar\u03b1 in lipid metabolism and inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.phymed.2026.157910_bib0006","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fgene.2019.00585","article-title":"Post-transcriptional gene regulation in Colitis Associated cancer","volume":"10","author":"Chen","year":"2019","journal-title":"Front. Genet."},{"issue":"17","key":"10.1016\/j.phymed.2026.157910_bib0007","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics."},{"key":"10.1016\/j.phymed.2026.157910_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178359","article-title":"Evaluation of the hepatoprotective effects and pharmacokinetics of pedunculoside in vitro and in vivo","volume":"1008","author":"Chen","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"20","key":"10.1016\/j.phymed.2026.157910_bib0009","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.3390\/ijms20205055","article-title":"Exploration and development of PPAR modulators in health and disease: an update of clinical evidence","volume":"20","author":"Cheng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phymed.2026.157910_bib0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/ph18020279","article-title":"Natural bioactive compounds in the management of type 2 diabetes and metabolic (Dysfunction)-associated steatotic liver disease","volume":"18","author":"Ciob\u00e2rc\u0103","year":"2025","journal-title":"Pharmaceuticals. (Basel)"},{"issue":"6","key":"10.1016\/j.phymed.2026.157910_bib0011","first-page":"401","article-title":"Silybin alleviates hepatic lipid accumulation in methionine-choline deficient diet-induced nonalcoholic fatty liver disease in mice via peroxisome proliferator-activated receptor \u03b1","volume":"19","author":"Cui","year":"2021","journal-title":"Chin. J. Nat. Med."},{"issue":"1","key":"10.1016\/j.phymed.2026.157910_bib0012","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jhep.2015.02.019","article-title":"PPAR\u03b1 gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis","volume":"63","author":"Francque","year":"2015","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.phymed.2026.157910_bib0013","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.31843","article-title":"Saroglitazar, a PPAR-\u03b1\/\u03b3 agonist, for treatment of NAFLD: a randomized controlled double-blind phase 2 trial","volume":"74","author":"Gawrieh","year":"2021","journal-title":"Hepatology"},{"issue":"D1","key":"10.1016\/j.phymed.2026.157910_bib0014","doi-asserted-by":"crossref","first-page":"D687","DOI":"10.1093\/nar\/gkab1028","article-title":"The reactome pathway knowledgebase 2022","volume":"50","author":"Gillespie","year":"2022","journal-title":"Nucleic. Acids. Res."},{"issue":"3","key":"10.1016\/j.phymed.2026.157910_bib0015","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3390\/ijms23031044","article-title":"Quercetin reduces lipid accumulation in a cell model of NAFLD by inhibiting De Novo Fatty acid synthesis through the acetyl-CoA carboxylase 1\/AMPK\/PP2A axis","volume":"23","author":"Gnoni","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.157910_bib0016","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/gutjnl-2024-332398","article-title":"Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma","volume":"74","author":"Ha","year":"2024","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.phymed.2026.157910_bib0017","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1177\/0091270011416937","article-title":"Pharmacokinetic-pharmacodynamic assessment of the interrelationships between tesaglitazar exposure and renal function in patients with type 2 diabetes mellitus","volume":"52","author":"Hamr\u00e9n","year":"2012","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.phymed.2026.157910_bib0018","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.molcel.2020.05.007","article-title":"Acetyl-CoA derived from hepatic peroxisomal \u03b2-oxidation inhibits autophagy and promotes steatosis via mTORC1 activation","volume":"79","author":"He","year":"2020","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.phymed.2026.157910_bib0019","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/s00018-008-8532-1","article-title":"Nuclear functions of heterogeneous nuclear ribonucleoproteins A\/B","volume":"66","author":"He","year":"2009","journal-title":"Cell Mol. Life Sci."},{"issue":"9","key":"10.1016\/j.phymed.2026.157910_bib0020","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1248\/bpb.b21-00232","article-title":"Structural basis for anti-non-alcoholic fatty liver disease and diabetic dyslipidemia drug Saroglitazar as a PPAR \u03b1\/\u03b3 dual agonist","volume":"44","author":"Honda","year":"2021","journal-title":"Biol. Pharm. Bull."},{"issue":"22","key":"10.1016\/j.phymed.2026.157910_bib0021","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216214","article-title":"Increase in hnRNPA1 expression suffices to kill motor neurons in transgenic rats","volume":"24","author":"Huang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2026.157910_bib0022","first-page":"984","article-title":"Scoparone alleviates nonalcoholic fatty liver disease by modulating the ppar\u03b1 signaling pathway","volume":"5","author":"Huang","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.phymed.2026.157910_bib0023","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.3390\/biom13081264","article-title":"Current clinical trial status and future prospects of PPAR-targeted drugs for treating nonalcoholic fatty liver disease","volume":"13","author":"Kamata","year":"2023","journal-title":"Biomolecules."},{"issue":"15","key":"10.1016\/j.phymed.2026.157910_bib0024","doi-asserted-by":"crossref","first-page":"19460","DOI":"10.18632\/aging.203357","article-title":"Pedunculoside protects against LPS-induced mastitis in mice by inhibiting inflammation and maintaining the integrity of blood-milk barrier","volume":"13","author":"Kan","year":"2021","journal-title":"Aging (Albany. NY)"},{"issue":"1","key":"10.1016\/j.phymed.2026.157910_bib0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.32221","article-title":"Breviscapine alleviates NASH by inhibiting TGF-\u03b2-activated kinase 1-dependent signaling","volume":"76","author":"Lan","year":"2022","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.phymed.2026.157910_bib0026","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/hep.31749","article-title":"Cordycepin ameliorates nonalcoholic steatohepatitis by activation of the AMP-activated protein kinase signaling pathway","volume":"74","author":"Lan","year":"2021","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.phymed.2026.157910_bib0027","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.3390\/ijms23084305","article-title":"PPAR-targeted therapies in the treatment of non-alcoholic fatty liver disease in diabetic patients","volume":"23","author":"Lange","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.157910_bib0028","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13020-024-01033-6","article-title":"Pedunculoside alleviates cognitive deficits and neuronal cell apoptosis by activating the AMPK signaling cascade","volume":"19","author":"Li","year":"2024","journal-title":"Chin. Med."},{"issue":"5","key":"10.1016\/j.phymed.2026.157910_bib0029","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2337\/db23-0609","article-title":"Adipocyte-specific Hnrnpa1 knockout aggravates obesity-induced metabolic dysfunction via upregulation of CCL2","volume":"73","author":"Li","year":"2024","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.phymed.2026.157910_bib0030","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s10735-024-10222-4","article-title":"Ameliorative effect of pedunculoside on sepsis-induced acute lung injury, inflammation and pulmonary fibrosis in mice model via suppressing AKT\/NF-\u03bab pathway","volume":"55","author":"Li","year":"2024","journal-title":"J. Mol. Histol."},{"issue":"7","key":"10.1016\/j.phymed.2026.157910_bib0031","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/1751-2980.12610","article-title":"Fatty liver mediated by peroxisome proliferator-activated receptor-alpha DNA methylation can be reversed by a methylation inhibitor and curcumin","volume":"19","author":"Li","year":"2018","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.phymed.2026.157910_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155285","article-title":"Formononetin promotes fatty acid \u03b2-oxidation to treat non-alcoholic steatohepatitis through SIRT1\/PGC-1\u03b1\/ppar\u03b1 pathway","volume":"124","author":"Liao","year":"2024","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.phymed.2026.157910_bib0033","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jhep.2024.09.038","article-title":"Risk of de novo HCC in patients with MASLD following direct-acting antiviral-induced cure of HCV infection","volume":"82","author":"Liu","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2026.157910_bib0034","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.biopha.2018.02.131","article-title":"Pedunculoside, a novel triterpene saponin extracted from Ilex rotunda, ameliorates high-fat diet induced hyperlipidemia in rats","volume":"101","author":"Liu","year":"2018","journal-title":"Biomed. PharmacOther"},{"key":"10.1016\/j.phymed.2026.157910_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107017","article-title":"The protective effect and mechanism of pedunculoside on DSS (dextran sulfate sodium) induced ulcerative colitis in mice","volume":"88","author":"Liu","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"10","key":"10.1016\/j.phymed.2026.157910_bib0036","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s11655-025-3832-y","article-title":"Pseudolaric acid B alleviates non-alcoholic fatty liver disease by targeting ppar\u03b1 to regulate lipid metabolism and promote mitochondrial biogenesis","volume":"31","author":"Liu","year":"2025","journal-title":"Chin. J. Integr. Med."},{"issue":"1","key":"10.1016\/j.phymed.2026.157910_bib0037","doi-asserted-by":"crossref","first-page":"119","DOI":"10.21037\/hbsn-23-556","article-title":"The global burden of fatty liver disease: the major impact of China","volume":"13","author":"Lou","year":"2024","journal-title":"Hepatobiliary. Surg. Nutr."},{"key":"10.1016\/j.phymed.2026.157910_bib0038","doi-asserted-by":"crossref","DOI":"10.1177\/09603271251322186","article-title":"Pedunculoside inhibits cardiomyocyte inflammatory biomarkers via Nrf2\/HO-1 pathway in high glucose-induced H9c2 cells and diabetic cardiomyopathy model rats","volume":"44","author":"Lu","year":"2025","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.phymed.2026.157910_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111344","article-title":"Danthron ameliorates obesity and MAFLD through activating the interplay between ppar\u03b1\/rxr\u03b1 heterodimer and adiponectin receptor 2","volume":"137","author":"Ma","year":"2021","journal-title":"Biomed. PharmacOther"},{"issue":"5","key":"10.1016\/j.phymed.2026.157910_bib0040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/03009742.2019.1600716","article-title":"Pedunculoside attenuates pathological phenotypes of fibroblast-like synoviocytes and protects against collagen-induced arthritis","volume":"48","author":"Ma","year":"2019","journal-title":"Scand. J. Rheumatol."},{"issue":"2","key":"10.1016\/j.phymed.2026.157910_bib0041","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jhep.2021.05.003","article-title":"The Chinese Society of Hepatology position statement on the redefinition of fatty liver disease","volume":"75","author":"Nan","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2026.157910_bib0042","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.chroma.2016.02.054","article-title":"Comprehensive untargeted lipidomic analysis using core-shell C30 particle column and high field orbitrap mass spectrometer","volume":"1440","author":"Narv\u00e1ez-Rivas","year":"2016","journal-title":"J. Chromatogr. A"},{"issue":"3","key":"10.1016\/j.phymed.2026.157910_bib0043","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of ppar\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2026.157910_bib0044","doi-asserted-by":"crossref","first-page":"m4747","DOI":"10.1136\/bmj.m4747","article-title":"Management of non-alcoholic fatty liver disease","volume":"372","author":"Petroni","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.phymed.2026.157910_bib0045","series-title":"Chinese Pharmacopoeia Commission Chinese Pharmacopoeia","year":"2025"},{"issue":"9","key":"10.1016\/j.phymed.2026.157910_bib0046","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/antiox13091026","article-title":"Tanshinone IIA inhibits the endoplasmic reticulum stress-induced unfolded protein response by activating the ppar\u03b1\/FGF21 axis to ameliorate nonalcoholic steatohepatitis","volume":"13","author":"Pi","year":"2024","journal-title":"Antioxidants. (Basel)"},{"issue":"1","key":"10.1016\/j.phymed.2026.157910_bib0047","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC. Endocr. Disord."},{"key":"10.1016\/j.phymed.2026.157910_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106786","article-title":"Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)","volume":"192","author":"Qiu","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"9","key":"10.1016\/j.phymed.2026.157910_bib0049","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"5","key":"10.1016\/j.phymed.2026.157910_bib0050","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.phymed.2026.157910_bib0051","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.phymed.2026.157910_bib0052","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.bbalip.2007.02.003","article-title":"Safety issues and prospects for future generations of PPAR modulators","volume":"1771","author":"Rubenstrunk","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phymed.2026.157910_bib0053","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8812634","article-title":"Diospyros kaki and citrus unshiu mixture improves disorders of lipid metabolism in nonalcoholic fatty liver disease","author":"Shin","year":"2020","journal-title":"Can. J. Gastroenterol. Hepatol."},{"issue":"16","key":"10.1016\/j.phymed.2026.157910_bib0054","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s00018-018-2838-4","article-title":"Role of peroxisome proliferator-activated receptors in non-alcoholic fatty liver disease inflammation","volume":"75","author":"Silva","year":"2018","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phymed.2026.157910_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155702","article-title":"Androsin alleviates non-alcoholic fatty liver disease by activating autophagy and attenuating de novo lipogenesis","volume":"129","author":"Singh","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.phymed.2026.157910_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122806","article-title":"Unravelling the complexities of non-alcoholic steatohepatitis: the role of metabolism, transporters, and herb-drug interactions","volume":"351","author":"Somabattini","year":"2024","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.phymed.2026.157910_bib0057","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-70242-8","article-title":"Efficacy and safety of Resmetirom, a selective thyroid hormone receptor-\u03b2 agonist, in the treatment of metabolic dysfunction-associated steatotic liver disease (MASLD): a systematic review and meta-analysis","volume":"14","author":"Suvarna","year":"2024","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.phymed.2026.157910_bib0058","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.phymed.2026.157910_bib0059","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1002\/hep.32068","article-title":"Gastrodin improves nonalcoholic fatty liver disease through activation of the adenosine monophosphate-activated protein kinase signaling pathway","volume":"74","author":"Wan","year":"2021","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.phymed.2026.157910_bib0060","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/hep.27406","article-title":"The global burden of liver disease: the major impact of China","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.phymed.2026.157910_bib0061","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2337\/db17-0799","article-title":"Long noncoding RNA lncSHGL recruits hnRNPA1 to suppress hepatic gluconeogenesis and lipogenesis","volume":"67","author":"Wang","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.phymed.2026.157910_bib0062","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12986-020-00466-8","article-title":"TET1 promotes fatty acid oxidation and inhibits NAFLD progression by hydroxymethylation of ppar\u03b1 promoter","volume":"17","author":"Wang","year":"2020","journal-title":"Nutr. Metab. (Lond)"},{"issue":"3","key":"10.1016\/j.phymed.2026.157910_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103910","article-title":"NAFLD and NASH: etiology, targets and emerging therapies","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov. Today"},{"issue":"44","key":"10.1016\/j.phymed.2026.157910_bib0064","doi-asserted-by":"crossref","first-page":"10717","DOI":"10.1021\/jf503334d","article-title":"Tormentic acid, a major component of suspension cells of Eriobotrya japonica, suppresses high-fat diet-induced diabetes and hyperlipidemia by glucose transporter 4 and AMP-activated protein kinase phosphorylation","volume":"62","author":"Wu","year":"2014","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.phymed.2026.157910_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103499","article-title":"Caffeine ameliorates metabolic-associated steatohepatitis by rescuing hepatic Dusp9","volume":"80","author":"Xin","year":"2025","journal-title":"Redox. Biol."},{"issue":"23","key":"10.1016\/j.phymed.2026.157910_bib0066","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1111\/bph.70161","article-title":"\u03b2-elemene ameliorates metabolic dysfunction-associated steatohepatitis by targeting PPAR\u03b1 in experimental diet-induced models","volume":"182","author":"Xiong","year":"2025","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.phymed.2026.157910_bib0067","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1021\/acs.analchem.8b01331","article-title":"Development of a high coverage pseudotargeted lipidomics method based on ultra-high performance liquid chromatography-mass spectrometry","volume":"90","author":"Xuan","year":"2018","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.phymed.2026.157910_bib0068","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hep.32538","article-title":"Intestinal peroxisome proliferator-activated receptor \u03b1-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis","volume":"77","author":"Yan","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2026.157910_bib0069","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2174\/1573412916999200423105153","article-title":"Quantification and pharmacokinetics study of pedunculoside in rats by using UPLC-MS\/MS","volume":"17","author":"Yang","year":"2021","journal-title":"Curr. Pharm. Anal."},{"key":"10.1016\/j.phymed.2026.157910_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118354","article-title":"Berberine directly targets AKR1B10 protein to modulate lipid and glucose metabolism disorders in NAFLD","volume":"332","author":"Yang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2026.157910_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157159","article-title":"Hyperacmotone A alleviates non-alcoholic steatohepatitis via regulating ppar\u03b1 signaling","volume":"147","author":"Yang","year":"2025","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.phymed.2026.157910_bib0072","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.clnu.2024.04.029","article-title":"Ketogenic diet time-dependently prevents NAFLD through upregulating the expression of antioxidant protein metallothionein-2","volume":"43","author":"You","year":"2024","journal-title":"Clin. Nutr."},{"issue":"5","key":"10.1016\/j.phymed.2026.157910_bib0073","doi-asserted-by":"crossref","first-page":"9084","DOI":"10.3390\/molecules20059084","article-title":"LC-MS\/MS determination and pharmacokinetic study of pedunculoside in rat plasma after oral administration of pedunculoside and ilex rotunda extract","volume":"20","author":"Zhao","year":"2015","journal-title":"Molecules."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326001492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711326001492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:51:16Z","timestamp":1777593076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711326001492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":73,"alternative-id":["S0944711326001492"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2026.157910","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pedunculoside ameliorates metabolic dysfunction-associated steatotic liver disease by targeting HNRNPA1 and modulating PPAR\u03b1 signaling pathway to enhance Mitochondrial Fatty Acid \u03b2-Oxidation","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2026.157910","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"157910"}}